Academic Journal

Provision for patients with hypertension on access to cost compensation of essential drugs ; Забезпечення права пацієнтів з гіпертонічною хворобою на доступність до компенсації вартості життєво необхідних лікарських засобів

التفاصيل البيبلوغرافية
العنوان: Provision for patients with hypertension on access to cost compensation of essential drugs ; Забезпечення права пацієнтів з гіпертонічною хворобою на доступність до компенсації вартості життєво необхідних лікарських засобів
المؤلفون: Shapovalova, V. A., Shapovalov, V. V., Sedakova, L. А.
المصدر: Фармацевтический журнал; № 4 (2014): Farmatsevtychnyi zhurnal; 83-89 ; Фармацевтичний журнал; № 4 (2014): Фармацевтичний журнал; 83-89 ; Farmatsevtychnyi zhurnal; No. 4 (2014): Farmatsevtychnyi zhurnal; 83-89 ; 2617-9628 ; 0367-3057
بيانات النشر: The State Expert Center of the Ministry of Health of Ukraine
سنة النشر: 2019
مصطلحات موضوعية: pharmaceutical and medical law, patients, hypertension, drugs, availability, reimbursement, фармацевтичне і медичне право, пацієнти, гіпертонічна хвороба, лікарські засоби, доступність, реімбурсація
الوصف: Hypertensive heart disease is one of the important factors that lead to an increase in the number of deaths and reduce the forecast life expectancy of patients with essential hypertension. The aim of the research was the question of the right for the hypertensive patients to have access to cost recovery of essential medicines in the leading countries of the world and in Ukraine with the positions of pharmaceutical and medical law. Material data of the research were the scientific literature on reimbursement of the medicines for patients of different contingents in the world; existing legal documents of Ukraine in the implementation of the pilot project «Hypertensive heart disease». Used documentary, systemic, legal, comparative and graphical analysis. In the study explored questions on realization of the right of hypertensive patients on accessibility to partial repay the costs of the life necessary remedy in Ukraine, as well as in the leading countries of the world from the perspective of the pharmaceutical and medical law. Made the analysisof the pharmaceutical market of medicines for the treatment of hypertension, for which established state regulation of pricesby international nonproprietary names and manufacturers.The ratio of foreign and of domestic manufacturers drugs involved in a pilot project of hypertension, is respectively 65% i 35%. Highlighted the shortcomings of lists of drugs that are introduced price controls pilot project on hypertension. Proposed periodically revise the lists of drugs for the pilot project of hypertension for partial reimbursement prices. ; Гипертоническая болезнь является одним из важнейших факторов, которые приводят к увеличению количества смертей и ухудшают прогноз по продолжительности жизни пациентов. Целью работы было исследование вопросов реализации права пациентов с гипертонической болезнью, доступности возмещения стоимости жизненно необходимых лекарственных средств в ведущих странах мира и в Украине с позиции фармацевтического и медицинского права.Материалом ...
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: Ukrainian
Relation: https://pharmj.org.ua/index.php/journal/article/view/353/324; https://pharmj.org.ua/index.php/journal/article/view/353
الاتاحة: https://pharmj.org.ua/index.php/journal/article/view/353
Rights: https://creativecommons.org/licenses/by/4.0
رقم الانضمام: edsbas.6AC6248C
قاعدة البيانات: BASE
ResultId 1
Header edsbas
BASE
edsbas.6AC6248C
893
3
Academic Journal
academicJournal
892.664306640625
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.6AC6248C&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => https://pharmj.org.ua/index.php/journal/article/view/353# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Provision for patients with hypertension on access to cost compensation of essential drugs ; Забезпечення права пацієнтів з гіпертонічною хворобою на доступність до компенсації вартості життєво необхідних лікарських засобів )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Shapovalova%2C+V%2E+A%2E%22">Shapovalova, V. A.</searchLink><br /><searchLink fieldCode="AR" term="%22Shapovalov%2C+V%2E+V%2E%22">Shapovalov, V. V.</searchLink><br /><searchLink fieldCode="AR" term="%22Sedakova%2C+L%2E+А%2E%22">Sedakova, L. А.</searchLink> )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Фармацевтический журнал; № 4 (2014): Farmatsevtychnyi zhurnal; 83-89 ; Фармацевтичний журнал; № 4 (2014): Фармацевтичний журнал; 83-89 ; Farmatsevtychnyi zhurnal; No. 4 (2014): Farmatsevtychnyi zhurnal; 83-89 ; 2617-9628 ; 0367-3057 )
Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => The State Expert Center of the Ministry of Health of Ukraine )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2019 )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22pharmaceutical+and+medical+law%22">pharmaceutical and medical law</searchLink><br /><searchLink fieldCode="DE" term="%22patients%22">patients</searchLink><br /><searchLink fieldCode="DE" term="%22hypertension%22">hypertension</searchLink><br /><searchLink fieldCode="DE" term="%22drugs%22">drugs</searchLink><br /><searchLink fieldCode="DE" term="%22availability%22">availability</searchLink><br /><searchLink fieldCode="DE" term="%22reimbursement%22">reimbursement</searchLink><br /><searchLink fieldCode="DE" term="%22фармацевтичне+і+медичне+право%22">фармацевтичне і медичне право</searchLink><br /><searchLink fieldCode="DE" term="%22пацієнти%22">пацієнти</searchLink><br /><searchLink fieldCode="DE" term="%22гіпертонічна+хвороба%22">гіпертонічна хвороба</searchLink><br /><searchLink fieldCode="DE" term="%22лікарські+засоби%22">лікарські засоби</searchLink><br /><searchLink fieldCode="DE" term="%22доступність%22">доступність</searchLink><br /><searchLink fieldCode="DE" term="%22реімбурсація%22">реімбурсація</searchLink> )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Hypertensive heart disease is one of the important factors that lead to an increase in the number of deaths and reduce the forecast life expectancy of patients with essential hypertension. The aim of the research was the question of the right for the hypertensive patients to have access to cost recovery of essential medicines in the leading countries of the world and in Ukraine with the positions of pharmaceutical and medical law. Material data of the research were the scientific literature on reimbursement of the medicines for patients of different contingents in the world; existing legal documents of Ukraine in the implementation of the pilot project «Hypertensive heart disease». Used documentary, systemic, legal, comparative and graphical analysis. In the study explored questions on realization of the right of hypertensive patients on accessibility to partial repay the costs of the life necessary remedy in Ukraine, as well as in the leading countries of the world from the perspective of the pharmaceutical and medical law. Made the analysisof the pharmaceutical market of medicines for the treatment of hypertension, for which established state regulation of pricesby international nonproprietary names and manufacturers.The ratio of foreign and of domestic manufacturers drugs involved in a pilot project of hypertension, is respectively 65% i 35%. Highlighted the shortcomings of lists of drugs that are introduced price controls pilot project on hypertension. Proposed periodically revise the lists of drugs for the pilot project of hypertension for partial reimbursement prices. ; Гипертоническая болезнь является одним из важнейших факторов, которые приводят к увеличению количества смертей и ухудшают прогноз по продолжительности жизни пациентов. Целью работы было исследование вопросов реализации права пациентов с гипертонической болезнью, доступности возмещения стоимости жизненно необходимых лекарственных средств в ведущих странах мира и в Украине с позиции фармацевтического и медицинского права.Материалом ... )
Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper )
Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => application/pdf )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => Ukrainian )
Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => https://pharmj.org.ua/index.php/journal/article/view/353/324; https://pharmj.org.ua/index.php/journal/article/view/353 )
Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://pharmj.org.ua/index.php/journal/article/view/353 )
Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => https://creativecommons.org/licenses/by/4.0 )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.6AC6248C )
RecordInfo Array ( [BibEntity] => Array ( [Languages] => Array ( [0] => Array ( [Text] => Ukrainian ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => pharmaceutical and medical law [Type] => general ) [1] => Array ( [SubjectFull] => patients [Type] => general ) [2] => Array ( [SubjectFull] => hypertension [Type] => general ) [3] => Array ( [SubjectFull] => drugs [Type] => general ) [4] => Array ( [SubjectFull] => availability [Type] => general ) [5] => Array ( [SubjectFull] => reimbursement [Type] => general ) [6] => Array ( [SubjectFull] => фармацевтичне і медичне право [Type] => general ) [7] => Array ( [SubjectFull] => пацієнти [Type] => general ) [8] => Array ( [SubjectFull] => гіпертонічна хвороба [Type] => general ) [9] => Array ( [SubjectFull] => лікарські засоби [Type] => general ) [10] => Array ( [SubjectFull] => доступність [Type] => general ) [11] => Array ( [SubjectFull] => реімбурсація [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Provision for patients with hypertension on access to cost compensation of essential drugs ; Забезпечення права пацієнтів з гіпертонічною хворобою на доступність до компенсації вартості життєво необхідних лікарських засобів [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Shapovalova, V. A. ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Shapovalov, V. V. ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Sedakova, L. А. ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 01 [Type] => published [Y] => 2019 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-locals [Value] => edsbas ) [1] => Array ( [Type] => issn-locals [Value] => edsbas.oa ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Фармацевтический журнал; № 4 (2014): Farmatsevtychnyi zhurnal; 83-89 ; Фармацевтичний журнал [Type] => main ) ) ) ) ) ) )
IllustrationInfo